Study of Cutaneous Manifestations in Patients with Polycystic Ovarian Syndrome Attending a Tertiary Care Centre
DOI:
https://doi.org/10.70749/ijbr.v3i2.556Keywords:
Polycystic ovary syndrome (PCOS), Cutaneous manifestations, Hirsutism, ObesityAbstract
Background: Polycystic ovary syndrome (PCOS) is a common reproductive, metabolic, and psychological condition affecting up to 18% of women. It often manifests with dermatological symptoms, which may provide early diagnostic clues. Understanding the frequency and characteristics of these cutaneous manifestations is essential for effective management. Objective: To determine the frequency of cutaneous manifestations associated with PCOS. Materials and Methods: This descriptive cross-sectional study was conducted in the Department of Dermatology, CMH Multan, from June to December 2024. A total of 219 adult non-pregnant females aged 18–40 years, fulfilling the Rotterdam-2003 diagnostic criteria for PCOS, were enrolled through non-probability consecutive sampling. Participants with other endocrine disorders or hormonal disturbances were excluded. Clinical and anthropometric data, including BMI and cutaneous manifestations (hirsutism, acne, androgenic alopecia, seborrhea, acanthosis nigricans, and skin tags), were recorded. Data were analyzed using SPSS v26, with a Chi-Square test applied for significance. Results: The mean age of participants was 24.15 ± 7.10 years, and the mean BMI was 25.84 ± 6.00 kg/m². Hirsutism (93.26%) was the most prevalent manifestation, followed by androgenic alopecia (91.80%), seborrhea (89.40%), and acne (85.60%). Acanthosis nigricans and skin tags were present in 56.30% and 33.20%, respectively. Obese participants exhibited significantly higher rates of hirsutism compared to non-obese participants (82.5% vs. 39.7%, p<0.0001). Conclusion: Cutaneous manifestations are frequent in PCOS, with obesity significantly exacerbating hirsutism. Early dermatological assessment can aid in timely diagnosis and management of PCOS.
Downloads
References
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022). Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology, 10(9), 668-680. https://doi.org/10.1016/s2213-8587(22)00163-2
Kim, J. J., Hwang, K. R., Lee, D., Kim, S., & Choi, Y. M. (2024). Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline. Human Reproduction, 39(5), 1072-1077. https://doi.org/10.1093/humrep/deae042
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic ovary syndrome: Etiology, current management, and future therapeutics. Journal of Clinical Medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454
Barber, T. M., & Franks, S. (2021). Obesity and polycystic ovary syndrome. Clinical Endocrinology, 95(4), 531-541. https://doi.org/10.1111/cen.14421
Sekhon, A. K., Zergham, A. S., Tserenpil, G., Mebasher, A., & Malik, B. H. (2020). The association between polycystic ovary syndrome and its dermatological manifestations. Cureus. https://doi.org/10.7759/cureus.6855
Abusailik, M. A., Muhanna, A. M., Almuhisen, A. A., Alhasanat, A. M., Alshamaseen, A. M., Bani Mustafa, S. M., & Nawaiseh, M. B. (2021). Cutaneous manifestation of polycystic ovary syndrome. Dermatology Reports, 13(2). https://doi.org/10.4081/dr.2021.8799
Artar, G., Tas, B., Turan, G., & Uckan, H. H. (2022). Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS). Gynecological Endocrinology, 38(12), 1104-1108. https://doi.org/10.1080/09513590.2022.2162496
Kaur, S., Gupta, S. K., Juneja, S. K., Kaur, S., & Rani, M. (2020). Study of cutaneous manifestations of polycystic ovarian syndrome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 9(4), 1627. https://doi.org/10.18203/2320-1770.ijrcog20201235
Yerram, C., Rao, G. V., & Kilaru, K. R. (2019). Study of cutaneous manifestations in patients with polycystic ovarian syndrome attending a tertiary care centre. International Journal of Research in Dermatology, 5(3), 481. https://doi.org/10.18203/issn.2455-4529.intjresdermatol20193229
World Health Organization. (2024). Obesity and overweight. WHO. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Sekhon, A. K., Zergham, A. S., Tserenpil, G., Mebasher, A., & Malik, B. H. (2020). The association between polycystic ovary syndrome and its dermatological manifestations. Cureus. https://doi.org/10.7759/cureus.6855
Artar, G., Tas, B., Turan, G., & Uckan, H. H. (2022). Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS). Gynecological Endocrinology, 38(12), 1104-1108. https://doi.org/10.1080/09513590.2022.2162496
Barber, T. M., & Franks, S. (2021). Obesity and polycystic ovary syndrome. Clinical Endocrinology, 95(4), 531-541. https://doi.org/10.1111/cen.14421
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022). Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology, 10(9), 668-680. https://doi.org/10.1016/s2213-8587(22)00163-2
Kim, J. J., Hwang, K. R., Lee, D., Kim, S., & Choi, Y. M. (2024). Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline. Human Reproduction, 39(5), 1072-1077. https://doi.org/10.1093/humrep/deae042
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.